在神经病性溶酶体储存障碍中进行基因疗法
A Donald1, C Horgan2, M J De Castro Lopez3
1Division of Neurosciences, University of Manchester, Manchester, UK; Department of Paediatric Neurology, Royal Manchester Children's Hospital, Manchester Foundation Trust, UK.
概括
基因和细胞疗法为神经病性溶酶体储存障碍提供了新的希望. 本综述涵盖了当前的方法,挑战和治疗这些罕见的神经退行性疾病的未来方向.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- lysosomal储存障碍 (LSDs) 是由酶缺乏引起的遗传性疾病,影响多个身体系统.
- 神经病变性LSDs特别导致神经退行,带来了重大挑战,特别是在儿科患者群体中.
- 尽管个体罕见,但这些疾病总体上构成了显著的负担,推动了治疗创新.
研究的目的:
- 审查目前基因和基于细胞的基因疗法对神经病性溶酶体储存障碍的现状.
- 为了比较基因治疗中的腺相关病毒 (AAV) 和病毒载体方法.
- 讨论开发和提供这些先进疗法的进展,挑战和未来方向.
主要方法:
- 对LSDs的基因和细胞疗法的现有文献的审查.
- 对AAV和lentiviral基因传递系统的比较分析.
- 讨论临床应用,治疗开发和合作策略.
主要成果:
- 基因和细胞疗法对治疗严重的儿科LSD表型有希望.
- 在基因治疗应用中,AAV和lentiviral载体显示出明显的优点和缺点.
- 取得了显著的进展,但在广泛的患者获取和治疗疗效方面仍然存在挑战.
结论:
- 结合治疗策略和加强合作对于推动LSD治疗至关重要.
- 解决治疗开发中的延迟对于为患者提供创新的治疗方法至关重要.
- 未来的努力应集中在优化治疗效果和促进跨学科合作伙伴关系,以克服治疗障碍.
相关概念视频
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:15Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723